APUS
AMEX · Biotechnology
Apimeds Pharmaceuticals Us I
$2.27
-0.09 (-3.81%)
Open$2.29
Previous Close$2.36
Day High$2.37
Day Low$2.20
52W High$59.70
52W Low$1.51
Volume—
Avg Volume48.8K
Market Cap4.12M
P/E Ratio—
EPS$-36.71
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 11.55M | 12.01M | 11.14M |
| Net Income | 858.8K | 710.2K | 724.1K |
| Profit Margin | 7.4% | 5.9% | 6.5% |
| EBITDA | 1.04M | 1.13M | 1.04M |
| Free Cash Flow | 935.0K | 714.0K | 1.10M |
| Rev Growth | -8.4% | +17.9% | -7.5% |
| Debt/Equity | 0.40 | 0.38 | 0.40 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |